United States · FDA National Drug Code directory
droxidopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70436-141_1af8aeac-14cf-4330-bf4e-3e50348268c1
- Product NDC
- 70436-141
- Form
- CAPSULE
- Composition / generic term
- droxidopa
- Labeler
- Slate Run Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211110
- Source listing expiry
- 20261231
Source-listed ingredients
- DROXIDOPA — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 CAPSULE in 1 BOTTLE (70436-141-06) · 70436-141-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →